ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 145 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,705 | -49.0% | 8,984 | -8.5% | 0.00% | – |
| Q2 2023 | $93,537 | +3.5% | 9,815 | +19.4% | 0.00% | – |
| Q1 2023 | $90,387 | -56.3% | 8,217 | -41.2% | 0.00% | – |
| Q4 2022 | $206,904 | +13.1% | 13,980 | +46.2% | 0.00% | – |
| Q3 2022 | $183,000 | +226.8% | 9,565 | +261.2% | 0.00% | – |
| Q2 2022 | $56,000 | +55.6% | 2,648 | +76.5% | 0.00% | – |
| Q3 2021 | $36,000 | -10.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $40,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |